EquipNet, a leading provider of surplus asset management solutions based in Canton, Mass., has announced in a press release that it has entered a reseller agreement with California-based Agilent ...

Our cells contain thousands of proteins that have gone largely undetected and unstudied until recent years: these are ...

In a world first, researchers at the Kennedy Institute, Oxford have mapped the cellular dynamics following treatment with the ...

We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...

Akamis Bio, a clinical-stage oncology company using a proprietary Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform to ...

A year after the first samRNA vaccine approval, experts say similar vaccines in development are likely to face scientific and ...

Researchers have discovered that methotrexate (MTX) therapy may substantially diminish vaccine-induced CD4 T cell activation ...

In one of our recent articles about 10 High Growth Non-Tech Stocks That Are Profitable in 2024, we talked about how the US ...

The Cambridge-GSK Translational Immunology Collaboration builds on an existing scientific relationship between the biopharma company and the university, with the aim of improving outcomes for patients ...

Explore our latest breakthroughs in RNA Interference Research. Learn more about our innovative pipeline today! @ RNA ...

European Patent Office to grant a patent for DRP® companion diagnostic for Allarity's stenoparib cancer therapy Patent applications for the Stenoparib DRP® are also pending in the US, Japan, China, Au ...

The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...